Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
Understanding your individual metabolic and genetic profile can support a more personalized conversation with your healthcare provider about whether semaglutide or an alternative GLP-1 therapy aligns with your specific physiology
Keep in contact with your medical team, show up to your routine exams and discuss any new symptoms. Jonathan S
This will affect the lifespan of the lithium polymer battery
You are not alone
The same mechanism is being deployed toward different clinical ends , and those ends influence everything from trial design to patient expectations